Fda (original) (raw)
Latest News for: fda
Safety concerns over doctors prescribing experimental weight loss drug not approved by FDA
CBS News 09 Jun 2026
There's a new safety concern about doctors prescribing one experimental weight loss treatment, retatrutide, that hasn't even been FDA approved yet. Adam Yamaguchi reports ... .
New cancer risk tool that flags patients early seeks FDA approval
Newsweek 09 Jun 2026
A new tool that identifies early cancer risk in patients is currently under review with the Food and Drug Administration (FDA), the company that developed the device informed Newsweek, ...
Cronus Pharma Introduces Pimobendan Chewable Tablets (First FDA-Approved Generic) for Veterinary Use
The Joplin Globe 09 Jun 2026
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Jun 9, 2026-- ... .
Alterity Therapeutics Achieves Alignment with U.S. FDA on Pivotal Phase 3 Program for ATH434 in ...
Nasdaq Globe Newswire 09 Jun 2026
– Successful End-of-Phase 2 meeting with FDA agreeing on key elements of the proposed Phase 3 design, including study population, dosing regimen, and treatment duration – ... .
Atavistik Bio Announces U.S. FDA Clearance of Investigational New Drug Application and Fast Track Designation ...
Nasdaq Globe Newswire 09 Jun 2026
Atavistik Bio announces U.S. FDA clearance of investigational new drug application and Fast Track Designation for ATV-601 for the treatment of HHT ... .
US FDA Grants Orphan Drug and Rare Pediatric Disease Designations to GEn1E Lifesciences’ Dual Signal ...
The Joplin Globe 09 Jun 2026
PALO ALTO, Calif.--(BUSINESS WIRE)--Jun 9, 2026-- ... .
Matisse Pharmaceuticals receives FDA Fast Track Designation for isupartob sodium in sepsis
Nasdaq Globe Newswire 09 Jun 2026
Matisse obtains FDA Fast Track Designation for isupartob sodium in sepsis. FDA's Fast Track is designed to get important new drugs to the patient earlier ... .
A Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus
Nasdaq Globe Newswire 09 Jun 2026
Issued on behalf of Conexeu Sciences Inc. Issued on behalf of Conexeu Sciences Inc ... .
Multi Radiance Medical Expands FDA-Cleared Indications with New Lateral Epicondylitis Clearance Following Successful Triple-Blind Clinical Trial
Times Argus 09 Jun 2026
SOLON, Ohio--(BUSINESS WIRE)--Jun 9, 2026-- ....
FDA Approves the First New Sunscreen Ingredient in 20 Years
Time Magazine 09 Jun 2026
Bemotrizinol is a powerful, broad-spectrum blocker of dangerous rays that has been used in Europe for years. .
FDA OKs first new sunscreen ingredient in more than 25 years
Lancaster Online 09 Jun 2026
market in more than 25 years.
U.S. FDA approves new sunscreen ingredient used for years in Europe and Asia
CTV 09 Jun 2026
.
FDA green-lights 1st new sunscreen ingredient in years
ABC7 09 Jun 2026
The Food and Drug Administration is green-lighting a new sunscreen ingredient. .
FDA allows popular sunscreen ingredient long used in Europe and Asia
NBC News 09 Jun 2026
The Food and Drug Administration on Tuesday expanded its list of allowed sunscreen ingredients to include the chemical compound bemotrizinol ... .
Imviva Biotech Receives FDA Investigational New Drug Approval for CTA313, a Dual-Targeted CD19/BCMA Allogeneic CAR-T ...
Nasdaq Globe Newswire 09 Jun 2026
Approval paves the way for CTA313 clinical study in the United States ...